37
Participants
Start Date
November 5, 2019
Primary Completion Date
April 16, 2021
Study Completion Date
April 17, 2021
INTERCEPT Treated Platelets
Apheresis platelet components in 100% plasma collected using the Trima separator, prepared with the INTERCEPT Blood System for Platelets (Test Platelets) and stored for 7days at 20-24°C with continuous agitation. Samples from the Test component will be processed with either the BEST or the Variant 1 procedure prior to radiolabeling. The radiolabeled autologous Test and Control platelets (approximately 10-30 mL) will be simultaneously administered intravenously into the subject.
Hoxworth Blood Center, Cincinnati
Bloodworks Northwest Research Institute, Seattle
Lead Sponsor
Cerus Corporation
INDUSTRY